Company Enfusion, Inc.

Equities

ENFN

US2928121043

Software

Market Closed - Nyse 01:30:02 07/05/2024 am IST 5-day change 1st Jan Change
9.78 USD +2.19% Intraday chart for Enfusion, Inc. +2.95% +0.82%

Business Summary

Enfusion, Inc. provides software-as-a-service (SaaS) platform for investment managers. The Company, through its software, analytics, and middle/back-office managed services, creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration. The Company's cloud-native, end-to-end solution gives its clients the ability to access and analyze investment information in real time, perform complex calculations and interact with markets electronically adding up to better, more informed investment decisions and actions. Its solution is highly configurable to different work streams, client segments and asset classes. The Company's solution includes portfolio management system, order and execution management system, accounting/general ledger system, Enfusion Analytics System and technology-powered, managed services. Its solution is utilized by a variety of users, including portfolio managers, traders, compliance officers, operational support staff and executive management.

Number of employees: 1,102

Sales per Business

USD in Million2022Weight2023Weight Delta
Platform Subscriptions
92.5 %
139 92.4 % 162 92.5 % +16.31%
Managed Services
6.7 %
10 6.5 % 12 6.7 % +19.88%
Other
0.7 %
2 1.1 % 1 0.7 % -25.12%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
59.9 %
93 61.7 % 105 59.9 % +12.61%
Asia Pacific
22.9 %
35 23.4 % 40 22.9 % +13.45%
Europe, Middle East and Africa
15.0 %
20 13.3 % 26 15.0 % +30.28%
Americas
2.3 %
2 1.5 % 4 2.3 % +72.52%

Managers

Managers TitleAgeSince
Founder 50 01/06/01
Director of Finance/CFO 54 19/22/19
Chief Tech/Sci/R&D Officer 35 01/16/01
Chief Operating Officer 53 27/11
General Counsel - 01/20/01
Corporate Officer/Principal - -
Human Resources Officer 51 07/21/07

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 07/21/07
Director/Board Member 57 01/21/01
Director/Board Member 63 01/19/01
Director/Board Member 65 07/21/07
Director/Board Member 35 01/21/01
Founder 50 01/06/01
Director/Board Member 57 01/22/01
Chairman 52 09/23/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,198,767 0 0 39.33 %
Stock B 1 90,877,036 50,768,004 ( 55.86 %) 0

Shareholders

NameEquities%Valuation
Financial Technology Ventures Management Co. LLC
36.10 %
32,440,463 36.10 % 300 M $
ICONIQ Capital LLC
15.62 %
14,039,594 15.62 % 130 M $
Brown Capital Management LLC
13.15 %
11,817,661 13.15 % 109 M $
HHLR Advisors Ltd. (Cayman Islands)
5.536 %
4,975,183 5.536 % 46 M $
4,682,016 5.210 % 43 M $
Vanguard Fiduciary Trust Co.
4.007 %
3,601,519 4.007 % 33 M $
Ararat Capital Management LP
2.875 %
2,583,415 2.875 % 24 M $
BlackRock Advisors LLC
2.652 %
2,383,130 2.652 % 22 M $
1,972,007 2.194 % 18 M $
12 West Capital Management LP
2.118 %
1,903,190 2.118 % 18 M $
NameEquities%Valuation
12,616,365 30.62 % 117 M $

Company contact information

Enfusion, Inc.

125 South Clark Street Suite 750

60603, Chicago

+

http://enfusion.com
address Enfusion, Inc.(ENFN)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
9.78 USD
Average target price
9.821 USD
Spread / Average Target
+0.42%
Consensus
  1. Stock Market
  2. Equities
  3. ENFN Stock
  4. Company Enfusion, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW